Evidence map›Paper›PMID 36034662›Full record

ArticleFrontiers in chemistry2022

Complanatuside alleviates inflammatory cell damage induced by pro-inflammatory cytokines in skin keratinocytes.

Xiao Wang, Xuetao Xu, Panpan Wu, Mengshuo Wu, Lishe Gan, Jingwei Jin, Rihui Wu, Wenfeng Liu, Kun Zhang, Dongli Li and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The therapeutic potential ofFrontiers in pharmacology · 2025
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiao WangSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen City, China.
Xuetao XuSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen City, China.
Panpan WuSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen City, China.
Mengshuo WuSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen City, China.
Lishe GanSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen City, China.
Jingwei JinSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen City, China.
Rihui WuSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen City, China.
Wenfeng LiuSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen City, China.
Kun ZhangSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen City, China.
Dongli LiInternational Healthcare Innovation Institute (Jiangmen), Jiangmen, China.
Xi ZhengDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytokine-mediated inflammatory response is considered a cause of skin lesion in COVID-19 patients. Complanatuside is a flavonol glycoside isolated from

Indexed as

complanatusideCOVID-19HaCaT cellspyroptosisskin inflammatory damage

Identifiers

PMID36034662
PMCPMC9399639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.